Brevan Howard Capital Management »

Apellis Pharmaceuticals shares owned by Brevan Howard Capital Management

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Brevan Howard Capital Management from 13F filings

Historical chart of Brevan Howard Capital Management investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Brevan Howard Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.1M 91k 22.63
2024-09-30 $575k 20k 28.84
2024-03-31 $612k 10k 58.78
2023-12-31 $260k 4.3k 59.86
2023-06-30 $207k 2.3k 91.10

More positions owned by Brevan Howard Capital Management

Alphabet Cap Stk Cl C Call Option (GOOG)
Ishares Bitcoin Trust Etf Shs Ben Int Call Option (IBIT)
Pdd Holdings Sponsored Ads Call Option (PDD)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Ishares Tr Iboxx Inv Cp Etf Call Option (LQD)
Dbx Etf Tr Xtrack Hrvst Csi Call Option (ASHR)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Coinbase Global Com Cl A Call Option (COIN)
Baidu Spon Adr Rep A Call Option (BIDU)
Agnico Call Option (AEM)
Alphabet Cap Stk Cl A Put Option (GOOGL)

View all positions for Brevan Howard Capital Management

Top funds holding Apellis Pharmaceuticals

venBio Select Advisor
Vanguard Group
Morgan Stanley
Wellington Management Company
Deep Track Capital
BlackRock
AQR Capital Management
Jennison Associates
State Street Corporation
EcoR1 Capital
UBS Group
Suvretta Capital Management
Polar Capital Holdings
Siren
OrbiMed Advisors

View all funds holding Apellis Pharmaceuticals